NCT06223204 - GLEAM: Noninvasive Glucose Measurement Using Impedance Tomography | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

April 10, 2024

Study Completion Date

April 10, 2024

Conditions

Diabetes Mellitus

Interventions

OTHER

Controlled euglycemia, hypoglycemia and hyperglycemia

EIT measurements are collected in different glycemic states (euglycemia, hypoglycemia and hyperglycemia). Venous blood glucose is measured using a gold-standard glucose analyzer.

Trial Locations (1)

Unknown

Department of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern